NCT02048371 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Adverse Event data is collected beginning from the time of treatment through 30 days following cessation of treatment or until serious adverse events resolve (up to 3 years).
- Other-event reporting threshold
- 5%
Participants who crossed over are included in the total number at risk in the treatment arm for each Cohort as those participants were receiving treatment at time of adverse event.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Cohort A: Liposarcoma | 28 / 39 | 26 / 39 | 25 / 39 |
| Cohort A: Liposarcoma, Placebo | 7 / 9 | 8 / 9 | 7 / 9 |
| Cohort B: Osteosarcoma | 24 / 33 | 26 / 33 | 26 / 33 |
| Cohort B: Osteosarcoma, Placebo | 7 / 9 | 6 / 9 | 8 / 9 |
| Cohort C: Ewing Sarcoma | 21 / 30 | 22 / 30 | 17 / 30 |
| Cohort D: Rhabdomyosarcoma | 4 / 6 | 2 / 6 | 4 / 6 |
| Cohort D: Pediatric | 2 / 4 | 1 / 4 | 2 / 4 |
| Cohort E: Mesenchymal Chondrosarcoma | 0 / 1 | 0 / 1 | 0 / 1 |
Serious adverse events
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 39
- num Events
- 4
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 9
- num Events
- 3
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 6
- num Events
- 3
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Anemia
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Low Phosphate
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 30
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Elevated AST/SGOT
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Amylase Elevation
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 6
- num Events
- 3
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Decreased WBC
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 2
- num At Risk
- 6
- num Events
- 3
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Hyperfibrinolysis
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Lipase Elevation
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 6
- num Events
- 5
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Thrombocytopenia
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 33
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Alkaline Phosphatase Elevated
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 33
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Loss of Vision, Left Eye
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 33
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Vision Loss, Right Eye
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 39
- num Events
- 4
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 33
- num Events
- 2
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 30
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Abdominal Pain
Other reported adverse events
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Anemia
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 10
- num At Risk
- 33
- num Events
- 19
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 12
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Hypertension
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 33
- num Events
- 3
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 9
- num Events
- 4
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Alkaline Phosphatase Elevated
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Blurred vision
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Vision Loss, Right Eye
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 33
- num Events
- 2
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 30
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Constipation
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 9
- num Events
- 2
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 33
- num Events
- 3
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 5
- num At Risk
- 30
- num Events
- 7
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Diarrhea
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 39
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 33
- num Events
- 7
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 9
- num Events
- 2
- group Id
- EG004
- num Affected
- 6
- num At Risk
- 30
- num Events
- 7
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Nausea
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 33
- num Events
- 5
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 30
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Vomiting
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 33
- num Events
- 4
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 30
- num Events
- 3
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Mucositis oral
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 39
- num Events
- 3
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 9
- num Events
- 2
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 33
- num Events
- 4
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 30
- num Events
- 3
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Fatigue
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 9
- num Events
- 2
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 33
- num Events
- 3
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 30
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Fever
Complete source fields
- description
- Participants who crossed over are included in the total number at risk in the treatment arm for each Cohort as those participants were receiving treatment at time of adverse event.
- event Groups
- deaths Num Affected
- 25
- deaths Num At Risk
- 39
- description
- Adults: 160 mg daily; 21 days on and 7 days off Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off Regorafenib Regorafenib: Adults: 160 mg daily; 21 days on and 7 days off Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off
- id
- EG000
- other Num Affected
- 26
- other Num At Risk
- 39
- serious Num Affected
- 28
- serious Num At Risk
- 39
- title
- Cohort A: Liposarcoma
- deaths Num Affected
- 7
- deaths Num At Risk
- 9
- description
- 21 days on and 7 days off Placebo Placebo: 21 days on and 7 days off
- id
- EG001
- other Num Affected
- 8
- other Num At Risk
- 9
- serious Num Affected
- 7
- serious Num At Risk
- 9
- title
- Cohort A: Liposarcoma, Placebo
- deaths Num Affected
- 26
- deaths Num At Risk
- 33
- description
- Adults: 160 mg daily; 21 days on and 7 days off Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off Regorafenib Regorafenib: Adults: 160 mg daily; 21 days on and 7 days off Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off
- id
- EG002
- other Num Affected
- 26
- other Num At Risk
- 33
- serious Num Affected
- 24
- serious Num At Risk
- 33
- title
- Cohort B: Osteosarcoma
- deaths Num Affected
- 8
- deaths Num At Risk
- 9
- description
- 21 days on and 7 days off Placebo Placebo: 21 days on and 7 days off
- id
- EG003
- other Num Affected
- 6
- other Num At Risk
- 9
- serious Num Affected
- 7
- serious Num At Risk
- 9
- title
- Cohort B: Osteosarcoma, Placebo
- deaths Num Affected
- 17
- deaths Num At Risk
- 30
- description
- Adults: 160 mg daily; 21 days on and 7 days off Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off Regorafenib Regorafenib: Adults: 160 mg daily; 21 days on and 7 days off Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off
- id
- EG004
- other Num Affected
- 22
- other Num At Risk
- 30
- serious Num Affected
- 21
- serious Num At Risk
- 30
- title
- Cohort C: Ewing Sarcoma
- deaths Num Affected
- 4
- deaths Num At Risk
- 6
- description
- Adults: 160 mg daily; 21 days on and 7 days off Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off Regorafenib Regorafenib: Adults: 160 mg daily; 21 days on and 7 days off Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off
- id
- EG005
- other Num Affected
- 2
- other Num At Risk
- 6
- serious Num Affected
- 4
- serious Num At Risk
- 6
- title
- Cohort D: Rhabdomyosarcoma
- deaths Num Affected
- 2
- deaths Num At Risk
- 4
- description
- Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off Regorafenib Regorafenib: Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off
- id
- EG006
- other Num Affected
- 1
- other Num At Risk
- 4
- serious Num Affected
- 2
- serious Num At Risk
- 4
- title
- Cohort D: Pediatric
- deaths Num Affected
- 0
- deaths Num At Risk
- 1
- description
- Adults: 160 mg daily; 21 days on and 7 days off Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off Regorafenib Regorafenib: Adults: 160 mg daily; 21 days on and 7 days off Pediatrics: 82mg/m2 (rounding to the nearest 20mg) daily; 21 days on and 7 days off
- id
- EG007
- other Num Affected
- 0
- other Num At Risk
- 1
- serious Num Affected
- 0
- serious Num At Risk
- 1
- title
- Cohort E: Mesenchymal Chondrosarcoma
- frequency Threshold
- 5
- other Events
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Anemia
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 10
- num At Risk
- 33
- num Events
- 19
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 12
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Hypertension
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 33
- num Events
- 3
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 9
- num Events
- 4
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Alkaline Phosphatase Elevated
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Blurred vision
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Vision Loss, Right Eye
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 33
- num Events
- 2
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 30
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Constipation
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 9
- num Events
- 2
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 33
- num Events
- 3
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 5
- num At Risk
- 30
- num Events
- 7
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Diarrhea
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 39
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 6
- num At Risk
- 33
- num Events
- 7
- group Id
- EG003
- num Affected
- 2
- num At Risk
- 9
- num Events
- 2
- group Id
- EG004
- num Affected
- 6
- num At Risk
- 30
- num Events
- 7
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Nausea
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 33
- num Events
- 5
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 30
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Vomiting
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 33
- num Events
- 4
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 30
- num Events
- 3
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Mucositis oral
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 39
- num Events
- 3
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 9
- num Events
- 2
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 33
- num Events
- 4
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 3
- num At Risk
- 30
- num Events
- 3
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Fatigue
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 9
- num Events
- 2
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 33
- num Events
- 3
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 30
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Fever
- serious Events
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 39
- num Events
- 4
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 9
- num Events
- 3
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 6
- num Events
- 3
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Anemia
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Low Phosphate
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 30
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Elevated AST/SGOT
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Amylase Elevation
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 6
- num Events
- 3
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Decreased WBC
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 2
- num At Risk
- 6
- num Events
- 3
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Hyperfibrinolysis
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 6
- num Events
- 1
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Lipase Elevation
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 33
- num Events
- 0
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 1
- num At Risk
- 6
- num Events
- 5
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Thrombocytopenia
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Endocrine disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 33
- num Events
- 1
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Alkaline Phosphatase Elevated
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 33
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Loss of Vision, Left Eye
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 39
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 33
- num Events
- 1
- group Id
- EG003
- num Affected
- 0
- num At Risk
- 9
- num Events
- 0
- group Id
- EG004
- num Affected
- 0
- num At Risk
- 30
- num Events
- 0
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Vision Loss, Right Eye
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTECA Version 4.03
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 39
- num Events
- 4
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 33
- num Events
- 2
- group Id
- EG003
- num Affected
- 1
- num At Risk
- 9
- num Events
- 1
- group Id
- EG004
- num Affected
- 1
- num At Risk
- 30
- num Events
- 1
- group Id
- EG005
- num Affected
- 0
- num At Risk
- 6
- num Events
- 0
- group Id
- EG006
- num Affected
- 0
- num At Risk
- 4
- num Events
- 0
- group Id
- EG007
- num Affected
- 0
- num At Risk
- 1
- num Events
- 0
- term
- Abdominal Pain
- time Frame
- Adverse Event data is collected beginning from the time of treatment through 30 days following cessation of treatment or until serious adverse events resolve (up to 3 years).
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle